Randomized, double-blind trial of the effect of fluid composition on electrolyte, acid-base, and fluid homeostasis in patients early after subarachnoid hemorrhage

Neurocritical Care

Volumn 18, Issue 1, 2013, Pages 5-12

  Lehmann, Laura ^a   Bendel, Stepani ^a   Uehlinger, Dominik E ^a   Takala, Jukka ^a   Schafer, Margaret ^a   Reinert, Michael ^a   Jakob, Stephan M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acid base balance; Fluid therapy; Osmolality; Subarachnoid hemorrhage

Indexed keywords

CHLORIDE; HETASTARCH; SODIUM; SODIUM CHLORIDE;

ACID BASE BALANCE; ADULT; ALKALOSIS; ARTICLE; CHLORIDE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROLYTE BALANCE; ELECTROLYTE BLOOD LEVEL; FEMALE; FLUID BALANCE; FLUID THERAPY; HEMODYNAMICS; HUMAN; HYPONATREMIA; INTRACRANIAL PRESSURE; MALE; OSMOLALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; SUBARACHNOID HEMORRHAGE; THERAPY EFFECT;

ACETATES; ADULT; AGED; CHLORIDES; COLLOIDS; DOUBLE-BLIND METHOD; ELECTROLYTES; FEMALE; FLUID THERAPY; HETASTARCH; HUMANS; HYPERNATREMIA; HYPONATREMIA; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; PLASMA SUBSTITUTES; SODIUM CHLORIDE; SUBARACHNOID HEMORRHAGE; WATER-ELECTROLYTE BALANCE; WATER-ELECTROLYTE IMBALANCE;

EID: 84873438892     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-012-9764-3     Document Type: Article

References (31)

1. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet. 1997;349:245-9.
2. Espiner EA, Leikis R, Ferch RD, et al. The neuro-cardio-endocrine response to acute subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2002;56:629-35.
3. Wartenberg KE, Schmidt JM, Claassen J, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34:617-23.
4. Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 1990;27:106-8.
5. Qureshi AI, Suri MF, Sung GY, et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 2002;50:749-55.
6. Mandal AK, Saklayen MG, Hillman NM, Markert RJ. Predictive factors for high mortality in hypernatremic patients. Am J Emerg Med. 1997;15:130-2.
7. Bennani SL, Abouqal R, Zeggwagh AA, et al. Incidence, causes and prognostic factors of hyponatremia in intensive care. Rev Med Interne. 2003;24:224-9.
8. Lee CT, Guo HR, Chen JB. Hyponatremia in the emergency department. Am J Emerg Med. 2000;18:264-8.
9. Tommasino C, Moore S, Todd MM. Cerebral effects of isovolemic hemodilution with crystalloid or colloid solutions. Crit Care Med. 1988;16:862-8.
10. Zornow MH, McQuitty C, Prough DS. Perioperative fluid management of the neurosurgical patient. In: Albin MS, editor. Textbook of neuroanesthesia with neurosurgical and neuroscience perspectives. New York: McGraw-Hill; 1997. p. 117-48.
11. Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer's solution versus 0.9 % sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999;88:999-1003.
12. O'Malley CM, Frumento RJ, Hardy MA, et al. A randomized, double-blind comparison of lactated Ringer's solution and 0.9 % NaCl during renal transplantation. Anesth Analg. 2005;100:1518-24.
13. Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93:811-6.
14. Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-7.
15. Sayama T, Inamura T, Matsushima T, Inoha S, Inoue T, Fukui M. High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms. Neurol Res. 2000;22:151-5.
16. Wijdicks EF, Vermeulen M, ten Haaf JA, Hijdra A, Bakker WH, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Ann Neurol. 1985;18:211-6.
17. Diringer MN, Wu KC, Verbalis JG, Hanley DF. Hypervolemic therapy prevents volume contraction but not hyponatremia following subarachnoid hemorrhage. Ann Neurol. 1992;31:543-50.
18. Solomon RA, Post KD, McMurtry JG 3rd. Depression of circulating blood volume in patients after subarachnoid hemorrhage: implications for the management of symptomatic vasospasm. Neurosurgery. 1984;15:354-61.
19. Hasan D, Lindsay KW, Wijdicks EF, et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 1989;20:1156-61.
20. Audibert G, Steinmann G, de Talancé N, et al. Endocrine response after severe subarachnoid hemorrhage related to sodium and blood volume regulation. Anesth Analg. 2009;108:1922-8.
21. Bederson JB, Connolly ES Jr, Batjer HH, American Heart Association, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 2009;40:994-1025.
22. Diringer M, Bleck T, Claude Hemphill J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's multidisciplinary consensus conference. Neurocrit Care. 2011;15:211-40.
23. Isotani E, Suzuki R, Tomita K, et al. Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke. 1994;25:2198-203.
24. Kurokawa Y, Uede T, Ishiguro M, et al. Pathogenesis of hyponatremia following subarachnoid hemorrhage due to ruptured cerebral aneurysm. Surg Neurol. 1996;46:500-7.
25. Wijdicks EF, Schievink WI, Burnett JC Jr. Natriuretic peptide system and endothelin in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1997;87:275-80.
26. Moro N, Katayama Y, Kojima J, Mori T, Kawamata T. Prophylactic management of excessive natriuresis with hydrocortisone for efficient hypervolemic therapy after subarachnoid hemorrhage. Stroke. 2003;34:2807-11.
27. Katayama Y, Haraoka J, Hirabayashi H, et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:2373-5.
28. Fukui S, Otani N, Katoh H, et al. Female gender as a risk factor for hypokalemia and QT prolongation after subarachnoid hemorrhage. Neurology. 2002;59:134-6.
29. Fukui S, Katoh H, Tsuzuki N, et al. Multivariate analysis of risk factors for QT prolongation following subarachnoid hemorrhage. Crit Care. 2003;7:R7-12.
30. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414-9.
31. Mayer SA, Lin J, Homma S, et al. Myocardial injury and left ventricular performance after subarachnoid hemorrhage. Stroke. 1999;30:780-6.